arrow
J

John Staffurth

Cardiff University
H指数:48
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COMPLETE PATHOLOGICAL RESPONSE OF THE PRIMARY TUMOUR AND IMPLICATIONS FOR CYTOREDUCTIVE TREATMENT IN DE NOVO METASTATIC PROSTATE CANCER: ANALYSIS FROM THE IP2-ATLANTA PHASE II RANDOMISED STUDY

原发肿瘤的完全病理缓解及其对去势抵抗性治疗的影响:IP2-ATLANTA II期随机研究的分析

2026-05-010
PRE
Two-year toxicity outcomes from PACE-C: Stereotactic Body Radiotherapy (SBRT) versus moderate hypofractionated radiotherapy (MHRT)

PACE-C研究中的两年毒性结局:立体定向体部放射治疗(SBRT)与中等分割低剂量率放射治疗(MHRT)

2025-10-140
PRE
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial

调强中低分割放射治疗与立体定向体部放射治疗用于前列腺癌的比较(PACE-C):一项随机、开放标签、III期非劣效性试验的早期毒性结果

2025-06-120
PRE
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial

联合细胞减灭术、放射治疗或消融术治疗原发性转移性前列腺癌:IP2-ATLANTA内部试点,II期,随机对照试验

2025-06-010
OAAI
The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study

盆腔放射性疾病(PRD)的专科胃肠病学服务的影响:前瞻性多中心EAGLE研究的结果

2025-01-290
OA
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
2024-10-171
PRE
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response

转移性去势抵抗性前列腺癌的镭223: 全身弥散加权磁共振成像扫描评估反应

2023-10-033
OAAI
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

前列腺癌监测、手术或放疗后的15年预后

2023-04-27295
OA
Rucaparib or Physician's Choice in Metastatic Prostate Cancer

Rucaparib或医生在转移性前列腺癌中的选择

2023-02-23161
OA
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
2022-06-017
OAAI
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

局限性前列腺癌治疗的功能和生活质量结果 (前列腺癌检测和治疗 [ProtecT] 研究)

2022-05-0347
OA
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

大分割放疗对前列腺癌患者报告结果的影响: CHHiP试验 (CRUK/06/016) 中长达5年的结果

2021-12-0119
OA
Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer
2021-06-0118
OAAI